Cargando…
Requirement for the Chemokine Receptor Ccr6 in Allergic Pulmonary Inflammation
Allergic asthmatic responses in the airway are associated with airway hyperreactivity, eosinophil accumulation in the lung, and cytokine production by allergen-specific, T helper cell type 2 (Th2) lymphocytes. Here, we show that in a cockroach antigen (CA) model of allergic pulmonary inflammation, t...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193496/ https://www.ncbi.nlm.nih.gov/pubmed/11514610 |
_version_ | 1782147484540207104 |
---|---|
author | Lukacs, Nicholas W. Prosser, Dina M. Wiekowski, Maria Lira, Sergio A. Cook, Donald N. |
author_facet | Lukacs, Nicholas W. Prosser, Dina M. Wiekowski, Maria Lira, Sergio A. Cook, Donald N. |
author_sort | Lukacs, Nicholas W. |
collection | PubMed |
description | Allergic asthmatic responses in the airway are associated with airway hyperreactivity, eosinophil accumulation in the lung, and cytokine production by allergen-specific, T helper cell type 2 (Th2) lymphocytes. Here, we show that in a cockroach antigen (CA) model of allergic pulmonary inflammation, the chemokine macrophage inflammatory protein (MIP)-3α is expressed in the lung within hours of allergen challenge. To determine the biologic relevance of this expression, mice lacking CCR6, the only known receptor for MIP-3α, were studied for their response to CA. CCR6-deficient mice were immunized to the same extent as their wild-type counterparts, as judged by cytokine production in antigen-challenged lymphocytes. However, compared with CA-challenged wild-type mice, challenged CCR6-deficient mice had reduced airway resistance, fewer eosinophils around the airway, lower levels of interleukin 5 in the lung, and reduced serum levels of immunoglobulin E. Together, these data demonstrate that MIP-3α and CCR6 function in allergic pulmonary responses and suggest that these molecules might represent novel therapeutic targets for treatment of asthma. |
format | Text |
id | pubmed-2193496 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2001 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-21934962008-04-14 Requirement for the Chemokine Receptor Ccr6 in Allergic Pulmonary Inflammation Lukacs, Nicholas W. Prosser, Dina M. Wiekowski, Maria Lira, Sergio A. Cook, Donald N. J Exp Med Brief Definitive Report Allergic asthmatic responses in the airway are associated with airway hyperreactivity, eosinophil accumulation in the lung, and cytokine production by allergen-specific, T helper cell type 2 (Th2) lymphocytes. Here, we show that in a cockroach antigen (CA) model of allergic pulmonary inflammation, the chemokine macrophage inflammatory protein (MIP)-3α is expressed in the lung within hours of allergen challenge. To determine the biologic relevance of this expression, mice lacking CCR6, the only known receptor for MIP-3α, were studied for their response to CA. CCR6-deficient mice were immunized to the same extent as their wild-type counterparts, as judged by cytokine production in antigen-challenged lymphocytes. However, compared with CA-challenged wild-type mice, challenged CCR6-deficient mice had reduced airway resistance, fewer eosinophils around the airway, lower levels of interleukin 5 in the lung, and reduced serum levels of immunoglobulin E. Together, these data demonstrate that MIP-3α and CCR6 function in allergic pulmonary responses and suggest that these molecules might represent novel therapeutic targets for treatment of asthma. The Rockefeller University Press 2001-08-20 /pmc/articles/PMC2193496/ /pubmed/11514610 Text en © 2001 The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Brief Definitive Report Lukacs, Nicholas W. Prosser, Dina M. Wiekowski, Maria Lira, Sergio A. Cook, Donald N. Requirement for the Chemokine Receptor Ccr6 in Allergic Pulmonary Inflammation |
title | Requirement for the Chemokine Receptor Ccr6 in Allergic Pulmonary Inflammation |
title_full | Requirement for the Chemokine Receptor Ccr6 in Allergic Pulmonary Inflammation |
title_fullStr | Requirement for the Chemokine Receptor Ccr6 in Allergic Pulmonary Inflammation |
title_full_unstemmed | Requirement for the Chemokine Receptor Ccr6 in Allergic Pulmonary Inflammation |
title_short | Requirement for the Chemokine Receptor Ccr6 in Allergic Pulmonary Inflammation |
title_sort | requirement for the chemokine receptor ccr6 in allergic pulmonary inflammation |
topic | Brief Definitive Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193496/ https://www.ncbi.nlm.nih.gov/pubmed/11514610 |
work_keys_str_mv | AT lukacsnicholasw requirementforthechemokinereceptorccr6inallergicpulmonaryinflammation AT prosserdinam requirementforthechemokinereceptorccr6inallergicpulmonaryinflammation AT wiekowskimaria requirementforthechemokinereceptorccr6inallergicpulmonaryinflammation AT lirasergioa requirementforthechemokinereceptorccr6inallergicpulmonaryinflammation AT cookdonaldn requirementforthechemokinereceptorccr6inallergicpulmonaryinflammation |